ES2683822T3 - Procedimiento para detectar sustancias específicas en la leche - Google Patents
Procedimiento para detectar sustancias específicas en la leche Download PDFInfo
- Publication number
- ES2683822T3 ES2683822T3 ES12878885.8T ES12878885T ES2683822T3 ES 2683822 T3 ES2683822 T3 ES 2683822T3 ES 12878885 T ES12878885 T ES 12878885T ES 2683822 T3 ES2683822 T3 ES 2683822T3
- Authority
- ES
- Spain
- Prior art keywords
- milk
- antibody
- procedure
- bacterium
- specific substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 112
- 235000013336 milk Nutrition 0.000 title claims abstract description 111
- 239000008267 milk Substances 0.000 title claims abstract description 111
- 210000004080 milk Anatomy 0.000 title claims abstract description 111
- 239000000126 substance Substances 0.000 title claims abstract description 84
- 241000894006 Bacteria Species 0.000 claims abstract description 62
- 239000002245 particle Substances 0.000 claims abstract description 57
- 238000012360 testing method Methods 0.000 claims abstract description 44
- 230000014759 maintenance of location Effects 0.000 claims abstract description 35
- 235000021243 milk fat Nutrition 0.000 claims abstract description 29
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 27
- 239000004094 surface-active agent Substances 0.000 claims abstract description 20
- 230000008030 elimination Effects 0.000 claims abstract description 9
- 238000003379 elimination reaction Methods 0.000 claims abstract description 9
- 239000003550 marker Substances 0.000 claims abstract description 6
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 claims description 32
- 238000001514 detection method Methods 0.000 claims description 26
- 239000000654 additive Substances 0.000 claims description 21
- 230000000996 additive effect Effects 0.000 claims description 21
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 230000009089 cytolysis Effects 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 4
- 241000191940 Staphylococcus Species 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 11
- 108090000790 Enzymes Proteins 0.000 abstract description 11
- 239000000243 solution Substances 0.000 description 48
- 239000000523 sample Substances 0.000 description 47
- 241000191967 Staphylococcus aureus Species 0.000 description 44
- 238000006243 chemical reaction Methods 0.000 description 28
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 24
- 208000004396 mastitis Diseases 0.000 description 22
- 239000012528 membrane Substances 0.000 description 21
- 238000011161 development Methods 0.000 description 19
- 238000005259 measurement Methods 0.000 description 18
- 244000005700 microbiome Species 0.000 description 17
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 239000000427 antigen Substances 0.000 description 14
- 102000036639 antigens Human genes 0.000 description 14
- 108091007433 antigens Proteins 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 13
- 238000010521 absorption reaction Methods 0.000 description 13
- 239000002953 phosphate buffered saline Substances 0.000 description 13
- 244000144972 livestock Species 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 235000013365 dairy product Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000011152 fibreglass Substances 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 235000020247 cow milk Nutrition 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229920001213 Polysorbate 20 Polymers 0.000 description 7
- 239000013504 Triton X-100 Substances 0.000 description 7
- 229920004890 Triton X-100 Polymers 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241001494479 Pecora Species 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- -1 cellulose nitrate ester Chemical class 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000003317 immunochromatography Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 102100025643 60S ribosomal protein L12 Human genes 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 108010000605 Ribosomal Proteins Proteins 0.000 description 3
- 102000002278 Ribosomal Proteins Human genes 0.000 description 3
- 102000008837 Ribosomal protein L7/L12 Human genes 0.000 description 3
- 108050000743 Ribosomal protein L7/L12 Proteins 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000002101 lytic effect Effects 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001420 bacteriolytic effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical group NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- 229910018994 (KOHYO) No Inorganic materials 0.000 description 1
- 108010055851 Acetylglucosaminidase Proteins 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 241000588621 Moraxella Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000201854 Staphylococcus chromogenes Species 0.000 description 1
- 241000192087 Staphylococcus hominis Species 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000194046 Streptococcus intermedius Species 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycine anhydride Natural products [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000009 lactational effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940098362 serratia marcescens Drugs 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229940037648 staphylococcus simulans Drugs 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/952—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Water Supply & Treatment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2012/065150 WO2013186885A1 (ja) | 2012-06-13 | 2012-06-13 | 乳汁中の特定物質を検出する方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2683822T3 true ES2683822T3 (es) | 2018-09-28 |
Family
ID=49757747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12878885.8T Active ES2683822T3 (es) | 2012-06-13 | 2012-06-13 | Procedimiento para detectar sustancias específicas en la leche |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10048262B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2863223B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6081457B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112014029814B1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK2863223T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2683822T3 (cg-RX-API-DMAC10.html) |
| IN (1) | IN2014DN10498A (cg-RX-API-DMAC10.html) |
| RU (1) | RU2617400C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013186885A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ721269A (en) * | 2013-12-18 | 2017-09-29 | Asahi Chemical Ind | Method for detecting streptococcus bacterium contained in milk |
| EP3085769B1 (en) * | 2013-12-18 | 2020-04-15 | Asahi Kasei Kabushiki Kaisha | Method for detecting coliform bacteria contained in milk |
| JP2017150815A (ja) * | 2014-05-29 | 2017-08-31 | 株式会社日立製作所 | 臨床検査キット及び化学物質検出方法 |
| US9968523B2 (en) * | 2015-03-30 | 2018-05-15 | Elwha Llc | Systems and devices for controlling delivery of breast milk supplementation |
| US10290372B2 (en) | 2015-03-30 | 2019-05-14 | Elwha Llc | Systems and devices for controlling delivery of breast milk supplementation |
| US9925122B2 (en) | 2015-03-30 | 2018-03-27 | Elwha Llc | Systems and methods for controlling delivery of breast milk supplementation |
| US10016341B2 (en) | 2015-03-30 | 2018-07-10 | Elwha Llc | Systems and devices for controlling delivery of breast milk supplementation |
| CA3087184A1 (en) * | 2017-12-28 | 2019-07-04 | Delaval Holding Ab | A dry stick |
| WO2020069002A2 (en) * | 2018-09-26 | 2020-04-02 | Adaptive Phage Therapeutics, Inc. | Monitoring host cell contamination of virus-based biological products |
| NZ776450A (en) | 2018-11-30 | 2024-11-29 | Asahi Chemical Ind | Method for detecting causative bacterium of mastitis |
| CN110618266A (zh) * | 2019-09-26 | 2019-12-27 | 河北省科学院生物研究所 | 一种检测奶牛乳腺炎的试剂盒及其使用方法 |
| EP4302090A1 (en) * | 2021-03-05 | 2024-01-10 | Zoetis Services LLC | Lateral flow assay for detecting pathogens in milk from mastitic cows |
| TWI769052B (zh) * | 2021-08-16 | 2022-06-21 | 國立臺灣師範大學 | 濃度顯示型甲醛檢測裝置 |
| EP4439065A4 (en) | 2021-11-24 | 2025-03-12 | Asahi Kasei Kabushiki Kaisha | Immunochromatography device and manufacturing method therefor, as well as method for detecting a target bacterium therewith |
| JP2024001901A (ja) * | 2022-06-23 | 2024-01-11 | デクセリアルズ株式会社 | 検査デバイス用基材、検査デバイス、及び検査デバイスの製造方法 |
| PL246485B1 (pl) * | 2022-08-25 | 2025-02-03 | Univ Jagiellonski | Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus |
| JP7756790B2 (ja) * | 2022-11-24 | 2025-10-20 | 旭化成株式会社 | 溶菌方法、溶菌助液、及び細菌の有無の判定方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663291A (en) | 1984-07-06 | 1987-05-05 | Becton, Dickinson And Company | Method for solubilizing microbial protein obtained from Chlamydia trachomatis |
| JPH0773511B2 (ja) | 1986-12-29 | 1995-08-09 | 味の素株式会社 | 微生物菌数測定法 |
| CA1312544C (en) | 1987-12-21 | 1993-01-12 | James L. Wilcox | Chromatographic binding assay devices and methods |
| EP0595993A4 (en) | 1991-07-25 | 1994-08-17 | Commw Scient Ind Res Org | Isolation of charged particles from fluids |
| US5837546A (en) * | 1993-08-24 | 1998-11-17 | Metrika, Inc. | Electronic assay device and method |
| CA2217210A1 (en) | 1995-05-09 | 1996-11-14 | Smithkline Diagnostics, Inc. | Devices and methods for separating cellular components of blood from liquid portion of blood |
| US7635597B2 (en) * | 1995-08-09 | 2009-12-22 | Bayer Healthcare Llc | Dry reagent particle assay and device having multiple test zones and method therefor |
| US6268478B1 (en) * | 1996-02-12 | 2001-07-31 | Cedars-Sinai Medical Center | Intracellular vitamin D binding protein |
| AU5895898A (en) * | 1996-12-20 | 1998-07-17 | Gamera Bioscience Corporation | An affinity binding-based system for detecting particulates in a fluid |
| JPH1128099A (ja) | 1997-05-12 | 1999-02-02 | Kikkoman Corp | 黄色ブドウ球菌の検出法 |
| US5985675A (en) * | 1997-12-31 | 1999-11-16 | Charm Sciences, Inc. | Test device for detection of an analyte |
| DE69830416T2 (de) | 1997-10-07 | 2005-11-10 | Ucb S.A. | Testvorrichtung und verfahren zur bestimmung von analyten in einem flüssigen milchprodukt |
| JP5219057B2 (ja) | 1998-07-31 | 2013-06-26 | 旭化成株式会社 | 微生物検出用抗体 |
| JP2003512624A (ja) | 1999-10-21 | 2003-04-02 | オイ メディックス バイオケミカ エービー | 蓋を備えた前処理部を持つ試験ストリップを備えた装置 |
| AU2209101A (en) * | 1999-12-29 | 2001-07-16 | Procaryo As | Diagnostic analytical method and kit |
| US6372513B1 (en) | 2000-04-19 | 2002-04-16 | Ansys Technologies, Inc. | Device and process for lateral flow saliva testing |
| JP4426122B2 (ja) | 2001-01-23 | 2010-03-03 | 株式会社ビーエル | 血中抗原検出方法及び装置 |
| JP2004538453A (ja) | 2001-07-18 | 2004-12-24 | スーリャン ゾー， | 全細胞を含有するサンプルに対するラテラルフローアッセイのための試験片 |
| US6720160B2 (en) * | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
| US20050260695A1 (en) | 2003-09-23 | 2005-11-24 | Genprime, Inc. | Methods, compositions, devices, and kits for detecting mastitis |
| CN1914512A (zh) * | 2003-12-30 | 2007-02-14 | 3M创新有限公司 | 增强细胞的细胞壁组分的信号检测的方法 |
| CN101002095B (zh) | 2004-06-07 | 2013-01-02 | 电化生研株式会社 | 色谱检测装置，检测方法和利用此的试剂盒 |
| US20060127886A1 (en) | 2004-12-15 | 2006-06-15 | Kaylor Rosann M | Sample-efficient lateral flow immunoassay |
| JP4889263B2 (ja) | 2005-08-30 | 2012-03-07 | 学校法人東京理科大学 | 検体処理方法、乳房炎の検査方法及び細菌性疾病検査キット |
| US7531632B2 (en) * | 2006-02-16 | 2009-05-12 | Gtc Biotherapeutics, Inc. | Clarification of transgenic milk using depth filtration |
| EP2067045B1 (en) | 2006-09-28 | 2020-08-05 | The Macfarlane Burnet Institute for Medical Research and Public Health Limited | Method for determining the cd4+ t-cell count and kit therefor |
| WO2009043149A1 (en) * | 2007-10-01 | 2009-04-09 | Mds Analytical Technologies, A Business Unit Of Mds Inc., Doing Business Through Its Sciex Division | Analysis of conjugated metabolites of alcohol consumption |
| US20120003662A1 (en) * | 2007-10-18 | 2012-01-05 | University Of Medicine And Dentistry Of New Jersey | Methods and Kits for Detecting Mastitis |
| US8183047B2 (en) * | 2007-10-18 | 2012-05-22 | University Of Medicine And Dentistry Of New Jersey | Methods of detecting mastitis by levels of proteasomes |
| JP2010008361A (ja) | 2008-06-30 | 2010-01-14 | Nippon Telegr & Teleph Corp <Ntt> | 病原体検出チップ及び病原体検出方法 |
| US9404160B2 (en) * | 2009-12-22 | 2016-08-02 | Becton, Dickinson And Company | Methods for the detection of microorganisms |
| PL2547361T3 (pl) | 2010-03-17 | 2021-02-22 | Socpra - Sciences Et Génie, S.E.C. | Bakteryjne składniki szczepionek pochodzące ze staphylococcus aureus i ich zastosowania |
| DK2756306T3 (da) * | 2011-09-16 | 2019-11-11 | Dsm Ip Assets Bv | Immunassay til påvisning af antibiotika |
-
2012
- 2012-06-13 IN IN10498DEN2014 patent/IN2014DN10498A/en unknown
- 2012-06-13 DK DK12878885.8T patent/DK2863223T3/en active
- 2012-06-13 JP JP2014521049A patent/JP6081457B2/ja active Active
- 2012-06-13 RU RU2014150350A patent/RU2617400C2/ru active
- 2012-06-13 BR BR112014029814-9A patent/BR112014029814B1/pt active IP Right Grant
- 2012-06-13 WO PCT/JP2012/065150 patent/WO2013186885A1/ja not_active Ceased
- 2012-06-13 ES ES12878885.8T patent/ES2683822T3/es active Active
- 2012-06-13 EP EP12878885.8A patent/EP2863223B1/en active Active
- 2012-06-13 US US14/406,557 patent/US10048262B2/en active Active
-
2018
- 2018-07-06 US US16/028,951 patent/US10545146B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2863223A4 (en) | 2016-07-20 |
| IN2014DN10498A (cg-RX-API-DMAC10.html) | 2015-08-21 |
| US20180321239A1 (en) | 2018-11-08 |
| RU2014150350A (ru) | 2016-08-10 |
| EP2863223A1 (en) | 2015-04-22 |
| US20150160212A1 (en) | 2015-06-11 |
| RU2617400C2 (ru) | 2017-04-24 |
| BR112014029814B1 (pt) | 2020-12-08 |
| DK2863223T3 (en) | 2018-08-13 |
| NZ702764A (en) | 2016-02-26 |
| JPWO2013186885A1 (ja) | 2016-02-01 |
| US10545146B2 (en) | 2020-01-28 |
| US10048262B2 (en) | 2018-08-14 |
| JP6081457B2 (ja) | 2017-02-15 |
| WO2013186885A1 (ja) | 2013-12-19 |
| BR112014029814A2 (pt) | 2018-04-17 |
| EP2863223B1 (en) | 2018-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10545146B2 (en) | Method for detecting specific substance in milk | |
| ES2699886T3 (es) | Procedimiento para la detección de estafilococos contenidos en la leche | |
| ES2787174T3 (es) | Procedimiento para detectar bacterias coliformes contenidas en la leche | |
| ES2771598T3 (es) | Procedimiento para detectar bacterias del género Streptococcus en la leche | |
| ES2976232T3 (es) | Métodos y dispositivos mejorados para un diagnóstico exacto de infecciones | |
| Intaramat et al. | Protein A/G-based immunochromatographic test for serodiagnosis of pythiosis in human and animal subjects from Asia and Americas | |
| KR101753580B1 (ko) | 브루셀라 캐니스 항원의 제조 방법 | |
| EP3889609A1 (en) | Method for detecting mastitis-causing bacteria | |
| JP6831643B2 (ja) | 細菌を検出する方法及びキット | |
| JP5693938B2 (ja) | 乳汁中の特定物質を検出する方法 | |
| JP2021156799A (ja) | 検体中のインフルエンザ菌と肺炎球菌の免疫学的同時検出方法、及びイムノクロマトグラフィー装置 | |
| US20260118369A1 (en) | Assays for detection and quantitation of human endotrophin | |
| JP6770805B2 (ja) | 検体中の特定の細菌を検出する方法 | |
| JP6387063B2 (ja) | 乳汁中の特定物質を検出する方法 | |
| KR102132964B1 (ko) | 쯔쯔가무시균 유래 엑소좀을 이용한 쯔쯔가무시병의 진단방법 | |
| WO2013006034A2 (en) | A diagnostic kit for the detection of early acute leptospirosis | |
| NZ702764B2 (en) | Method for detecting specific substance in milk | |
| JP5829467B2 (ja) | レジオネラ菌に起因する病態の検査方法 | |
| Gupta et al. | KatG protein: A novel marker for differential diagnosis of Myobacterium avium complex infection | |
| JP2009195195A (ja) | 口腔内レンサ球菌の測定方法 |